Accuracy of congenital anomaly coding in live birth children recorded in European health care databases, a EUROlinkCAT study.


Journal

European journal of epidemiology
ISSN: 1573-7284
Titre abrégé: Eur J Epidemiol
Pays: Netherlands
ID NLM: 8508062

Informations de publication

Date de publication:
Mar 2023
Historique:
received: 22 07 2022
accepted: 28 01 2023
pubmed: 23 2 2023
medline: 25 3 2023
entrez: 22 2 2023
Statut: ppublish

Résumé

Electronic health care databases are increasingly being used to investigate the epidemiology of congenital anomalies (CAs) although there are concerns about their accuracy. The EUROlinkCAT project linked data from eleven EUROCAT registries to electronic hospital databases. The coding of CAs in electronic hospital databases was compared to the (gold standard) codes in the EUROCAT registries. For birth years 2010-2014 all linked live birth CA cases and all children identified in the hospital databases with a CA code were analysed. Registries calculated sensitivity and Positive Predictive Value (PPV) for 17 selected CAs. Pooled estimates for sensitivity and PPV were then calculated for each anomaly using random effects meta-analyses. Most registries linked more than 85% of their cases to hospital data. Gastroschisis, cleft lip with or without cleft palate and Down syndrome were recorded in hospital databases with high accuracy (sensitivity and PPV ≥ 85%). Hypoplastic left heart syndrome, spina bifida, Hirschsprung's disease, omphalocele and cleft palate showed high sensitivity (≥ 85%), but low or heterogeneous PPV, indicating that hospital data was complete but may contain false positives. The remaining anomaly subgroups in our study, showed low or heterogeneous sensitivity and PPV, indicating that the information in the hospital database was incomplete and of variable validity. Electronic health care databases cannot replace CA registries, although they can be used as an additional ascertainment source for CA registries. CA registries are still the most appropriate data source to study the epidemiology of CAs.

Identifiants

pubmed: 36807730
doi: 10.1007/s10654-023-00971-z
pii: 10.1007/s10654-023-00971-z
pmc: PMC10033551
doi:

Types de publication

Journal Article Meta-Analysis

Langues

eng

Sous-ensembles de citation

IM

Pagination

325-334

Subventions

Organisme : Horizon 2020 Framework Programme
ID : 733001

Informations de copyright

© 2023. The Author(s).

Références

Pharmacoepidemiol Drug Saf. 2021 Feb;30(2):266-274
pubmed: 33219586
J Public Health Manag Pract. 2016 May-Jun;22(3):E9-E19
pubmed: 26125231
PLoS One. 2021 Aug 27;16(8):e0256535
pubmed: 34449798
Birth Defects Res. 2023 Feb 1;115(3):405-412
pubmed: 36573578
Public Health Rep. 1990 May-Jun;105(3):296-307
pubmed: 2113690
BMJ Open. 2021 Jun 28;11(6):e047859
pubmed: 34183346
Public Health Rep. 2018 May/Jun;133(3):303-310
pubmed: 29620432
Birth Defects Res A Clin Mol Teratol. 2011 Mar;91 Suppl 1:S2-15
pubmed: 21384531
Epidemiol Prev. 2013 Jul-Oct;37(4-5):279-88
pubmed: 24293493
Birth Defects Res. 2021 Nov;113(18):1313-1323
pubmed: 34431628
Pharmacoepidemiol Drug Saf. 2013 Jan;22(1):7-15
pubmed: 22753079
Popul Health Metr. 2015 Dec 24;13:36
pubmed: 26705395
Pharmacoepidemiol Drug Saf. 2013 Aug;22(8):881-9
pubmed: 23616437
J Perinatol. 2005 Nov;25(11):737-42
pubmed: 16163368
J Public Health Manag Pract. 2010 May-Jun;16(3):245-51
pubmed: 20357611
Birth Defects Res A Clin Mol Teratol. 2006 Nov;76(11):757-61
pubmed: 17094134
Birth Defects Res. 2019 Nov 1;111(18):1365-1379
pubmed: 31414582
Paediatr Perinat Epidemiol. 2017 Jan;31(1):67-75
pubmed: 27859434
Paediatr Perinat Epidemiol. 2021 May;35(3):292-301
pubmed: 33258502
Birth Defects Res A Clin Mol Teratol. 2014 Feb;100(2):59-66
pubmed: 24307632

Auteurs

Marian K Bakker (MK)

Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. m.k.bakker@umcg.nl.

Maria Loane (M)

Institute for Nursing and Health Research, Ulster University, Northern Ireland, Newtownabbey, UK.

Ester Garne (E)

Department of Paediatrics and Adolescent Medicine, Lillebaelt Hospital, University Hospital of Southern Denmark, Kolding, Denmark.

Elisa Ballardini (E)

Neonatal Intensive Care Unit, Paediatric Section, IMER Registry (Emilia Romagna Registry of Birth Defects), Department of Medical Sciences, University of Ferrara, Ferrara, Italy.

Clara Cavero-Carbonell (C)

Rare Diseases Research Unit, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region, Valencia, Spain.

Laura García (L)

Rare Diseases Research Unit, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region, Valencia, Spain.

Mika Gissler (M)

Finnish Institute for Health and Welfare (THL), Helsinki, Finland.

Joanne Given (J)

Institute for Nursing and Health Research, Ulster University, Northern Ireland, Newtownabbey, UK.

Anna Heino (A)

Finnish Institute for Health and Welfare (THL), Helsinki, Finland.

Anna Jamry-Dziurla (A)

Polish Registry of Congenital Malformations, Chair and Department of Medical Genetics, University of Medical Sciences, Poznan, Poland.

Sue Jordan (S)

Faculty of Medicine, Health and Life Science, Swansea University, Swansea, UK.

Stine Kjaer Urhoj (SK)

Department of Paediatrics and Adolescent Medicine, Lillebaelt Hospital, University Hospital of Southern Denmark, Kolding, Denmark.
Section of Epidemiology, Department of Public Health, University of Copenhagen, Copenhagen, Denmark.

Anna Latos-Bieleńska (A)

Polish Registry of Congenital Malformations, Chair and Department of Medical Genetics, University of Medical Sciences, Poznan, Poland.

Elisabeth Limb (E)

Population Health Research Institute, St George's University of London, London, UK.

Renee Lutke (R)

Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Amanda J Neville (AJ)

IMER Registry, Centre for Epidemiology and Clinical Research, University of Ferrara and Azienda, Ospedaliero Universitario Di Ferrara, Ferrara, Italy.

Anna Pierini (A)

Unit of Epidemiology of Rare Diseases and Congenital Anomalies, Institute of Clinical Physiology, National Research Council, Pisa, Italy.

Michele Santoro (M)

Unit of Epidemiology of Rare Diseases and Congenital Anomalies, Institute of Clinical Physiology, National Research Council, Pisa, Italy.

Ieuan Scanlon (I)

Faculty of Medicine, Health and Life Science, Swansea University, Swansea, UK.

Joachim Tan (J)

Population Health Research Institute, St George's University of London, London, UK.

Diana Wellesley (D)

University of Southampton and Wessex Clinical Genetics Service, Princess Anne Hospital, Southampton, SO16 5YA, UK.

Hermien E K de Walle (HEK)

Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Joan K Morris (JK)

Population Health Research Institute, St George's University of London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH